Abstract
Globally active companies are involved in the discursive construction of moral legitimacy. Establishing normative conformance is problematic given the plurality of norms and values worldwide, and is particularly difficult for companies operating in morally controversial industries. In this paper, we investigate how organizations publicly legitimize the trade of human tissue for private profit when this practice runs counter to deep-seated and widespread moral beliefs. To do so, we use inductive, qualitative methods to analyze the website discourse of three types of organizations that trade in human tissue and are associated with different degrees of moral controversy with respect to tissue procurement and use. Our analysis reveals an object-oriented approach to moral legitimizing centered on the human tissue as a morally disputed good. We find that the website discourse translates human tissue into technology, constructs normative meaning around a dominant instrumental value associated with human-tissue-as-technology, and reproduces and stabilizes this meaning by six discursive mechanisms that amplify and anchor it. Moreover, the use of amplifying and anchoring discourse was greater in organizations associated with greater controversy. The results are consistent with an object-oriented sociality.
Similar content being viewed by others
References
Adelstein, J., & Clegg, S. (2016). Code of ethics: A stratified vehicle for compliance. Journal of Business Ethics, 138(1), 53–66.
Adobor, H. (2012). Ethical issues in outsourcing: The case of contract medical research and the global pharmaceutical industry. Journal of Business Ethics, 105(2), 239–255.
Almeling, R. (2007). Selling genes, selling gender. Egg agencies, sperm banks, and the medical market in genetic material. American Sociological Review, 72(3), 319–340.
Andrews, L., & Nelkin, D. (1998). Whose body is it anyway? Disputes over body tissue in a biotechnology age. The Lancet, 351(3), 53–57.
Anteby, M. (2010). Markets, morals, and practices of trade: Jurisdictional disputes in the U.S. commerce in cadavers. Administrative Science Quarterly, 55(4), 606–638.
Ashforth, B. E., & Gibbs, B. W. (1990). The double-edge of organizational legitimation. Organization Science, 1(2), 177–194.
Aßländer, M. S., Gössling, T., & Seele, P. (2016). Business ethics in a European perspective: A case for unity in diversity? Journal of Business Ethics, 139(4), 633–637.
Baumann-Pauly, D., Scherer, A. G., & Palazzo, G. (2016). Managing institutional complexity: A longitudinal study of legitimacy strategies at a sportswear brand company. Journal of Business Ethics, 137(1), 31–51.
Benford, R. D., & Snow, D. A. (2000). Framing processes and social movements: An overview and assessment. Annual Review of Sociology, 26, 611–639.
Bitektine, A. (2011). Toward a theory of social judgments of organizations: The case of legitimacy, reputation, and status. Academy of Management Review, 36(1), 151–179.
Byrne, E. F. (2014). Towards enforceable bans on illicit businesses: From moral relativism to human rights. Journal of Business Ethics, 119(1), 119–130.
Cai, Y., Jo, H., & Pan, C. (2012). Doing well while doing bad? CSR in controversial industry sectors. Journal of Business Ethics, 108(4), 467–480.
Callon, M. (1986). Some elements of a sociology of translation: Domestication of the scallops and the fishermen at St. Brieuc Bay. In J. Law (Ed.), Power, action and belief: A new sociology of knowledge? (pp. 196–223). London: Routledge.
Chelli, M., Durocher, S., & Fortin, A. (2016). Normativity in environmental reporting: A comparison of three regimes. Journal of Business Ethics. doi:10.1007/s10551-016-3128-4.
Chipulu, M., Marshall, A., Ojiako, U., & Mota, C. (2015). Reasoned ethical engagement: Ethical values of consumers as primary antecedents of instrumental actions towards multinationals. Journal of Business Ethics. doi:10.1007/s10551-015-2994-5.
Corbin, J., & Strauss, A. (2008). Basics of qualitative research: Techniques and procedures for developing grounded theory (3rd ed.). Thousand Oaks, CA: Sage.
Crowston, K., & Williams, M. (2000). Reproduced and emergent genres of communication on the World Wide Web. The Information Society, 16(3), 201–215.
Culler, J. (2001). The pursuit of signs: Semiotics, literature, deconstruction. Ithaca, NY: Cornell University Press.
Devers, C. E., Dewett, T., Mishina, Y., & Belsito, C. A. (2009). A general theory of organizational stigma. Organization Science, 20(1), 154–171.
Edmondson, A., & McManus, S. (2007). Methodological fit in management field research. Academy of Management Review, 32(4), 1155–1179.
Eisenhardt, K. M., & Graebner, M. E. (2007). Theory building from cases: Opportunities and challenges. Academy of Management Journal, 50(1), 25–32.
Galvin, T. L., Ventresca, M. J., & Hudson, B. A. (2005). Contested industry dynamics: New directions in the study of institutions and legitimacy. International Studies in Management and Organization, 34(4), 56–82.
Glaser, B. G., & Strauss, A. L. (2011). The discovery of grounded theory: Strategies for qualitative research. Chicago, IL: Aldine Publishing Company.
Glassner, B. (2004). Narrative techniques of fear mongering. Social Research, 71(4), 819–826.
Glynn, M. A., & Navis, C. (2013). Categories, identities, and cultural classification: Moving beyond a model of categorical constraint. Journal of Management Studies, 50(6), 1124–1137.
Goffman, E. (1974). Frame analysis: An essay on the organization of experience. Cambridge, MA: Harvard University Press.
Haase, M., & Raufflet, E. (2016). Ideologies in markets, organizations, and business ethics: Drafting a map. Journal of Business Ethics. doi:10.1007/s10551-016-3302-8.
Hay, R., Macy, M., & Shannon, J. (Eds.). (1981). Catalogue of strains II. Rockville, MD: American Type Culture Collections.
Hoeyer, K. (2008). The ethics of research biobanking: A critical review of the literature. Biotechnology and Genetic Engineering Reviews, 25(1), 429–452.
Hogle, L. F. (1999). Recovering the nation’s body: Cultural memory, medicine, and the politics of redemption. New Brunswick, NJ: Rutgers University Press.
Hudson, B. A. (2008). Against all odds: A consideration of core-stigmatized organizations. Academy of Management Review, 33(1), 252–266.
Hudson, B. A., & Okhuysen, G. A. (2009). Not with a ten-foot pole: Core stigma, stigma transfer, and improbable persistence of men’s bathhouses. Organization Science, 20(1), 134–153.
Human Tissue Authority. (2007). Human tissue (quality and safety for human application) regulations 2007. London: Human Tissue Authority.
International Consortium of Investigative Journalists. (2012). Skin and bone: The shadowy trade in human body parts. Retrieved from http://www.icij.org/tissue.
Kaplan, S. (2008). Framing contests: Strategy making under uncertainty. Organization Science, 19(5), 729–752.
Karimi-Busheri, F. (2015). Biobanking in the 21st century. New York: Springer International Publishing.
Kennedy, M. T. (2008). Getting counted: Markets, media, and reality. American Sociological Review, 73(2), 270–295.
Kirby, T. (2012). Profiteering threatens the altruism of tissue donation. The Lancet, 380(9854), 1635–1636.
Knorr Cetina, K. (1997). Sociality with objects: Social relations in postsocial knowledge societies. Theory, Culture & Society, 14(4), 1–31.
Kuhn, T. (2008). A communicative theory of the firm: Developing an alternative perspective on intra-organizational power and stakeholder relationships. Organization Studies, 29(8), 1227–1254.
Lamin, A., & Zaheer, S. (2012). Wall Street vs. Main Street: Firm strategies for defending legitimacy and their impact on different stakeholders. Organization Science, 23(1), 47–66.
Latour, B. (2005). Reassembling the social: An introduction to actor network theory. Oxford: Oxford University Press.
Mantere, S., Schildt, H. A., & Sillince, J. A. A. (2012). Reversal of strategic change. Academy of Management Journal, 55(1), 172–196.
Muller, K. (2011). Genre in the design space. Computers and Compositions, 28(3), 186–194.
Navis, C., & Glynn, M. A. (2010). How new market categories emerge: Temporal dynamics of legitimacy, identity, and entrepreneurship in satellite radio, 1990–2005. Administrative Science Quarterly, 55(3), 439–471.
Pablo, Z., & Hardy, C. (2009). Merging, masquerading and morphing: Metaphors and the World Wide Web. Organization Studies, 30(8), 821–843.
Palazzo, G., & Scherer, A. G. (2006). Corporate legitimacy as deliberation: A communicative framework. Journal of Business Ethics, 66(1), 71–88.
Pfau, M. W. (2007). Who’s afraid of fear appeals? Contingency, courage and deliberation in rhetorical theory and practice. Philosophy & Rhetoric, 40(2), 216–237.
Poitras, G., & Meredith, L. (2009). Ethical transparency and economic medicalization. Journal of Business Ethics, 86(3), 313–325.
Reuber, A. R., & Fischer, E. (2009). Organizations behaving badly: When are discredible actions likely to damage organizational reputation? Journal of Business Ethics, 93(1), 39–50.
Richardson, R. (1996). Fearful symmetry: Corpses for anatomy, organs for transplantation? In S. J. Youngner, R. C. Fox, & L. J. O’Connell (Eds.), Organ transplantation: Meanings and realities (pp. 66–100). Madison: University of Wisconsin Press.
Riegman, P. H. J., & van Veen, E. B. (2011). Biobanking residual tools. Human Genetics, 130(3), 357–368.
Roth, A. E. (2007). Repugnance as a constraint on markets. Journal of Economic Perspectives, 21(3), 37–58.
Scheper-Hughes, N. (2000). The global traffic in human organs. Current Anthropology, 41(2), 191–224.
Scherer, A. G., & Palazzo, G. (2007). Toward a political conception of corporate responsibility: Business and society seen from a Habermasian perspective. Academy of Management Review, 32(4), 1096–1120.
Scherer, A. G., & Palazzo, G. (2011). The new political role of business in a globalized world: A review of a new perspective on CSR and its implications for the firm, governance, and democracy. Journal of Management Studies, 48(4), 899–930.
Schrempf-Stirling, J. (2014). Roche’s clinical trials with organs from prisoners: Does profit trump morals? Journal of Business Ethics, 121(2), 315–328.
Scott, W. R. (2008). Institutions and organizations: Ideas and interests. Los Angeles, CA: Sage.
Scott, C. T., Caulfield, T., Borgelt, E., & Illes, J. (2012). Personal medicine—The new banking crisis. Nature Biotechnology, 30(2), 141–147.
Seele, P., & Lock, I. (2015). Instrumental and/or deliberative? A typology of CSR communication tools. Journal of Business Ethics, 131(2), 401–414.
Sharp, L. A. (2000). The commodification of the body and its parts. Annual Review of Anthropology, 29, 287–328.
Siminoff, L. A., Traino, H. M., & Gordon, N. (2010). Determinants of family consent to tissue donation. Journal of Trauma, Injury, Infection, and Critical Care, 69(4), 956–963.
Somiari, S. B., & Somiari, R. I. (2015). The future of biobanking: A conceptual look at how biobanks can respond to the growing human biospecimen needs of researchers. In F. Karimi-Busheri (Ed.), Biobanking in the 21st century (pp. 11–27). New York: Springer International Publishing.
Steinsbekk, K. S., Ursin, L. O., Skolbekken, J. A., & Solberg, B. (2013). We’re not in it for the money—Lay people’s moral institutions on commercial use of ‘their’ biobank. Medicine, Health Care and Philosophy, 16(2), 151–162.
Strauss, A. L. (2003). Qualitative analysis for social scientists. Cambridge: Cambridge University Press.
Suchman, M. C. (1995). Managing legitimacy: Strategic and institutional approaches. Academy of Management Review, 20(3), 571–610.
Suddaby, R., & Greenwood, R. (2005). Rhetorical strategies of legitimacy. Administrative Science Quarterly, 50(1), 35–67.
Talbot, D., & Boiral, O. (2015). Strategies for climate change and impression management: A case study among Canada’s large industrial emitters. Journal of Business Ethics, 132(2), 329–346.
Tassé, A. M. (2011). Biobanking and deceased persons. Human Genetics, 130(3), 415–423.
Tata, J., & Prasad, S. (2015). CSR communication: An impression management perspective. Journal of Business Ethics, 132(4), 765–778.
U.S. Food and Drug Administration. (2013). Tissue and tissue products. Retrieved from http://www.fda.gov/biologicsbloodvaccines/tissuetissueproducts/default.htm.
Utgård, J. (2015). Retail chains’ corporate social responsibility communication. Journal of Business Ethics. doi:10.1007/s10551-015-2952-2.
van Liedekerke, L., & Dubbink, W. (2008). Twenty years of European business ethics—Past developments and future concerns. Journal of Business Ethics, 82(2), 273–280.
van Veen, E. B., Riegman, P. H., Dinjens, W. N., Lam, K. H., Oomen, M. H., Spatz, A., et al. (2006). TuBaFrost 3: Regulatory and ethical issues on the exchange of residual tissue for research across Europe. European Journal of Cancer, 42(17), 2914–2923.
Vaught, J., Rogers, J., Carolin, T., & Compton, C. (2011). Biobankonomics: Developing a sustainable business model approach for the formation of a human tissue biobank. Journal of the National Cancer Institute Monographs, 42, 24–31.
Vergne, J. (2012). Stigmatized categories and public disapproval of organizations: A mixed methods study of the global arms industry, 1996–2007. Academy of Management Journal, 55(5), 1027–1052.
Weber, M. (1922/1978). In G. Roth & C. Wittich (Eds.), Economy and society. Berkeley and Los Angeles: University of California Press.
Wilson, A., & West, C. (1981). The marketing of ‘unmentionables’. Harvard Business Review, 59(1), 91–102.
Windscheid, L., Bowes-Sperry, L., Jonsen, K., & Morner, M. (2016). Managing organizational gender diversity images: A content analysis of German corporate websites. Journal of Business Ethics. doi:10.1007/s10551-016-3292-6.
Yates, J., & Orlikowski, W. J. (1992). Genres of organizational communication: A structurational approach to studying communication and media. Academy of Management Review, 17(2), 299–326.
Zika, E., Paci, D., Tobias, S. in den Bäumen, Braun, A., RijKers-Defrasne, S., Deschênes, M., Fortier, I., Laage-Hellman, J., Scerri, C.A., & Ibarreta, D. (2010). Biobanks in Europe: Prospects for harmonisation and networking. http://jrc.es/EURdoc/JRC57831.pdf. Accessed 1 March 2017.
Acknowledgements
The authors are grateful for the research assistance of Laurence Dessart, Hayley Dilazzaro, Cassandra Nakamura, Dottie Omino and Ian Thomson and for the financial assistance of the Adam Smith Research Foundation and the University of Toronto’s Work-Study Program. The paper has benefited enormously from the valuable comments and suggestions on earlier versions from Michel Anteby, Robert Chia, Eileen Fischer, Robin Holt, Trish Reay, András Tilcsik, Scott Vitell, participants at the EGOS 2013 Workshop on the Communicative Constitution of Organizations, and two anonymous reviewers.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Rebecca Reuber has received financial assistance for this research from the Adam Smith Research Foundation at the University of Glasgow and from the University of Toronto’s Work-Study program. Anna Morgan-Thomas declares that she has no conflict of interest.
Ethical Approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Rights and permissions
About this article
Cite this article
Reuber, A.R., Morgan-Thomas, A. Communicating Moral Legitimacy in Controversial Industries: The Trade in Human Tissue. J Bus Ethics 154, 49–63 (2019). https://doi.org/10.1007/s10551-017-3480-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10551-017-3480-z